{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:16:04Z","timestamp":1780539364451,"version":"3.54.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2023-00285353"],"award-info":[{"award-number":["RS-2023-00285353"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.heliyon.2024.e40108","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T03:40:48Z","timestamp":1730518848000},"page":"e40108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Antibacterial and antibiofilm features of mutSMAP-18 against Vibrio cholerae"],"prefix":"10.1016","volume":"10","author":[{"given":"Ishrat","family":"Jahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byambasuren","family":"Ganbaatar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Heui","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5648-5938","authenticated-orcid":false,"given":"Sungtae","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.heliyon.2024.e40108_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15598","article-title":"Cholera prevention, control strategies, challenges and World Health Organization initiatives in the Eastern Mediterranean Region: a narrative review","volume":"9","author":"Buliva","year":"2023","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e40108_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1995-7645(11)60149-1","article-title":"Cholera: a great global concern","volume":"4","author":"Mandal","year":"2011","journal-title":"Asian Pac. J. Tropical Med."},{"key":"10.1016\/j.heliyon.2024.e40108_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-021-00985-w","article-title":"Global status of tetracycline resistance among clinical isolates of Vibrio cholerae: a systematic review and meta-analysis","volume":"10","author":"Ahmadi","year":"2021","journal-title":"Antimicrob. Resist. Infect. Control"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e40108_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012638","article-title":"Phenotypic and antibiogram pattern of V. cholerae isolates from a tertiary care hospital in Mumbai during 2004\u20132013: a retrospective cross-sectional study","volume":"6","author":"Torane","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.heliyon.2024.e40108_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0140-6736(03)15328-7","article-title":"Cholera","volume":"363","author":"Sack","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e40108_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/infdis\/129.1.45","article-title":"Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum","volume":"129","author":"Cash","year":"1974","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e40108_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1099\/jmm.0.023051-0","article-title":"Antibiotic resistance mechanisms of Vibrio cholerae","volume":"60","author":"Kitaoka","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e40108_bib8","doi-asserted-by":"crossref","unstructured":"R.M. Maier, I.L. Pepper, C.P. Gerba, Environmental microbiology, Academic press2009.","DOI":"10.1016\/B978-0-12-370519-8.00001-8"},{"key":"10.1016\/j.heliyon.2024.e40108_bib9","series-title":"Oral Rehydration Salts: Production of the New ORS","author":"Organization","year":"2006"},{"issue":"8112","key":"10.1016\/j.heliyon.2024.e40108_bib10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(79)92889-7","article-title":"Rapid emergence of El Tor vibrio cholera resistant to antimicrobial agents during first six months of fourth cholera epidemic in Tanzania","volume":"313","author":"Mhalu","year":"1979","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e40108_bib11","first-page":"747","article-title":"Resistance to antimicrobial agents of Vibrio cholerae El Tor strains isolated during the fourth cholera epidemic in the United Republic of Tanzania","volume":"58","author":"Towner","year":"1980","journal-title":"Bull. World Health Organ."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e40108_bib12","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1128\/AAC.45.5.1605-1606.2001","article-title":"Emergence of fluoroquinolone-resistant strains of Vibrio cholerae O1 biotype El Tor among hospitalized patients with cholera in Calcutta, India","volume":"45","author":"Garg","year":"2001","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"10.1016\/j.heliyon.2024.e40108_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijid.2014.12.025","article-title":"Emergence and spread of tetracycline resistant Vibrio cholerae O1 El Tor variant during 2010 cholera epidemic in the tribal areas of Odisha, India","volume":"33","author":"Kar","year":"2015","journal-title":"Int. J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e40108_bib14","doi-asserted-by":"crossref","DOI":"10.3949\/ccjm.68.6.496","article-title":"Microbial drug resistance and the roles of the new antibiotics","volume":"68","author":"Longworth","year":"2001","journal-title":"Cleve. Clin. J. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e40108_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1086\/524891","article-title":"The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America","volume":"46","author":"Spellberg","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"10325","key":"10.1016\/j.heliyon.2024.e40108_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"The lancet"},{"key":"10.1016\/j.heliyon.2024.e40108_bib17","unstructured":"W.H. Organization, Global antimicrobial resistance and use surveillance system (GLASS) report 2022, World Health Organization2022."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e40108_bib18","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"issue":"6870","key":"10.1016\/j.heliyon.2024.e40108_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"nature"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e40108_bib20","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2174\/1568026616666160713143331","article-title":"Antimicrobial peptides under clinical trials","volume":"17","author":"E Greber","year":"2017","journal-title":"Current topics in medicinal chemistry"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e40108_bib21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/21505594.2016.1213475","article-title":"Activity of antimicrobial peptides, alone or combined with conventional antibiotics, against Staphylococcus aureus isolated from the airways of cystic fibrosis patients","volume":"8","author":"Garbacz","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.heliyon.2024.e40108_bib22","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.3389\/fmicb.2017.02633","article-title":"Bovine lactoferrin and lactoferrin-derived peptides inhibit the growth of Vibrio cholerae and other Vibrio species","volume":"8","author":"Acosta-Smith","year":"2018","journal-title":"Front. Microbiol."},{"issue":"6862","key":"10.1016\/j.heliyon.2024.e40108_bib23","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/35106587","article-title":"Innate antimicrobial peptide protects the skin from invasive bacterial infection","volume":"414","author":"Nizet","year":"2001","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e40108_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1164\/rccm.200307-971OC","article-title":"Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock","volume":"169","author":"Giacometti","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e40108_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0014-5793(99)01600-2","article-title":"SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes","volume":"463","author":"Skerlavaj","year":"1999","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e40108_bib26","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1006\/bbrc.2001.5280","article-title":"Structure\u2013activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide","volume":"285","author":"Shin","year":"2001","journal-title":"Biochemical and biophysical research communications"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e40108_bib27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ddr.20329","article-title":"Cathelicidin peptide SMAP\u201029: comprehensive review of its properties and potential as a novel class of antibiotics","volume":"70","author":"Dawson","year":"2009","journal-title":"Drug Dev. Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e40108_bib28","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ijantimicag.2011.01.007","article-title":"Analogues of peptide SMAP-29 with comparable antimicrobial potency and reduced cytotoxicity","volume":"37","author":"Dawson","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e40108_bib29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijantimicag.2010.06.038","article-title":"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis","volume":"36","author":"Dawson","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.heliyon.2024.e40108_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00726-013-1616-8","article-title":"Bacterial killing mechanism of sheep myeloid antimicrobial peptide-18 (SMAP-18) and its Trp-substituted analog with improved cell selectivity and reduced mammalian cell toxicity","volume":"46","author":"Jacob","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.heliyon.2024.e40108_bib31","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00726-016-2170-y","article-title":"The stereochemical effect of SMAP-29 and SMAP-18 on bacterial selectivity, membrane interaction and anti-inflammatory activity","volume":"48","author":"Jacob","year":"2016","journal-title":"Amino Acids"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e40108_bib32","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1046\/j.0014-2956.2002.02751.x","article-title":"SMAP\u201029 has two LPS\u2010binding sites and a central hinge","volume":"269","author":"Tack","year":"2002","journal-title":"Eur. J. Biochem."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e40108_bib33","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/s41598-023-28386-6","article-title":"Discovery of structural and functional transition sites for membrane-penetrating activity of sheep myeloid antimicrobial peptide-18","volume":"13","author":"Jung","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e40108_bib34","author":"Wayne","year":"2015","journal-title":"Clinical and laboratory standards institute (CLSI), Performance standards for antimicrobial susceptibility testing"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e40108_bib35","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3390\/biom14060699","article-title":"Enhancing selective antimicrobial and antibiofilm activities of melittin through 6-aminohexanoic acid substitution","volume":"14","author":"Radhakrishnan","year":"2024","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e40108_bib36","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1038\/s41598-022-08247-4","article-title":"A novel hybrid peptide composed of LfcinB6 and KR-12-a4 with enhanced antimicrobial, anti-inflammatory and anti-biofilm activities","volume":"12","author":"Ajish","year":"2022","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e40108_bib37","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3390\/ph16101356","article-title":"Multifunctional properties of BMAP-18 and its aliphatic analog against drug-resistant bacteria","volume":"16","author":"Jahan","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e40108_bib38","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nprot.2010.71","article-title":"Microtiter susceptibility testing of microbes growing on peg lids: a miniaturized biofilm model for high-throughput screening","volume":"5","author":"Harrison","year":"2010","journal-title":"Nat. Protoc."},{"issue":"26","key":"10.1016\/j.heliyon.2024.e40108_bib39","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1039\/C7OB01028A","article-title":"Antimicrobial peptide-inspired NH125 analogues: bacterial and fungal biofilm-eradicating agents and rapid killers of MRSA persisters","volume":"15","author":"Basak","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.heliyon.2024.e40108_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00005-009-0057-2","article-title":"Cathelicidin LL-37: a multitask antimicrobial peptide","volume":"58","author":"Bucki","year":"2010","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e40108_bib41","first-page":"475","article-title":"Response of toxigenic Vibrio cholerae 01 to physico-chemical stresses in aquatic environments","volume":"93","author":"Miller","year":"1984","journal-title":"Epidemiol. Infect."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e40108_bib42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0005-2728(00)00286-3","article-title":"Role of sodium bioenergetics in Vibrio cholerae","volume":"1505","author":"H\u00e4se","year":"2001","journal-title":"Biochimica et Biophysica Acta (BBA)-Bioenergetics"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e40108_bib43","doi-asserted-by":"crossref","first-page":"15694","DOI":"10.1021\/acsomega.9b02278","article-title":"Conjugation of cell-penetrating peptides to antimicrobial peptides enhances antibacterial activity","volume":"4","author":"Lee","year":"2019","journal-title":"ACS Omega"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e40108_bib44","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00726-023-03290-5","article-title":"Rationally designed PMAP-23 derivatives with enhanced bactericidal and anticancer activity based on the molecular mechanism of peptide\u2013membrane interactions","volume":"55","author":"Lee","year":"2023","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e40108_bib45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40543-023-00398-x","article-title":"Effect of central PxxP motif in amphipathic alpha-helical peptides on antimicrobial activity and mode of action","volume":"14","author":"Lee","year":"2023","journal-title":"Journal of Analytical Science and Technology"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e40108_bib46","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/bkcs.12091","article-title":"Improved cell selectivity of symmetric \u03b1\u2010helical peptides derived from trp\u2010rich antimicrobial peptides","volume":"41","author":"Lee","year":"2020","journal-title":"Bull. Kor. Chem. Soc."},{"key":"10.1016\/j.heliyon.2024.e40108_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170106","article-title":"Structural analysis and mode of action of BMAP-27, a cathelicidin-derived antimicrobial peptide","volume":"118","author":"Yang","year":"2019","journal-title":"Peptides"},{"issue":"18","key":"10.1016\/j.heliyon.2024.e40108_bib48","doi-asserted-by":"crossref","first-page":"9752","DOI":"10.3390\/ijms22189752","article-title":"The central PXXP motif is crucial for PMAP-23 translocation across the lipid bilayer","volume":"22","author":"Yang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e40108_bib49","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/jac\/dkn058","article-title":"In vitro and in vivo antimicrobial activity of granulysin-derived peptides against Vibrio cholerae","volume":"61","author":"Galvao da Silva","year":"2008","journal-title":"Journal of antimicrobial chemotherapy (Print)"},{"key":"10.1016\/j.heliyon.2024.e40108_bib50","doi-asserted-by":"crossref","first-page":"A83","DOI":"10.1016\/j.vaccine.2019.06.031","article-title":"Antibiotic resistance in Vibrio cholerae: understanding the ecology of resistance genes and mechanisms","volume":"38","author":"Das","year":"2020","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e40108_bib51","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1039\/D0CS00729C","article-title":"The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions","volume":"50","author":"Gan","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e40108_bib52","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1039\/D0CS01026J","article-title":"Chemically modified and conjugated antimicrobial peptides against superbugs","volume":"50","author":"Li","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.heliyon.2024.e40108_bib53","article-title":"Enhancing the stability of antimicrobial peptides: from design strategies to biomedical applications","author":"Xu","year":"2023","journal-title":"Chem. Eng. J."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e40108_bib54","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijantimicag.2008.04.003","article-title":"Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp","volume":"32","author":"Chou","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"16","key":"10.1016\/j.heliyon.2024.e40108_bib55","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.1073\/pnas.0601277103","article-title":"Transmissibility of cholera: in vivo-formed biofilms and their relationship to infectivity and persistence in the environment","volume":"103","author":"Faruque","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e40108_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tim.2008.12.004","article-title":"Vibrio biofilms: so much the same yet so different","volume":"17","author":"Yildiz","year":"2009","journal-title":"Trends Microbiol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e40108_bib57","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-micro-111021-053553","article-title":"Mechanisms underlying Vibrio cholerae biofilm formation and dispersion","volume":"76","author":"Teschler","year":"2022","journal-title":"Annu. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e40108_bib58","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrmicro3433","article-title":"Living in the matrix: assembly and control of Vibrio cholerae biofilms","volume":"13","author":"Teschler","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e40108_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004330","article-title":"Vibrio cholerae biofilms and cholera pathogenesis","volume":"10","author":"Silva","year":"2016","journal-title":"PLoS Neglected Trop. Dis."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024161397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024161397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:39:42Z","timestamp":1775457582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024161397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":59,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2405844024161397"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40108","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibacterial and antibiofilm features of mutSMAP-18 against Vibrio cholerae","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e40108"}}